Köhler & Milstein Research

Mérida, Yucatán 97070

0 studies enrolling now · 5 studies all time

What they study most

Covid19, Pneumonia, Pneumonia, Viral, Psoriasis, Rheumatoid Arthritis, SARS (Severe Acute Respiratory Syndrome), SARS Pneumonia, SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere, Systemic Lupus Erythematosus

Studies at this site

• Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects — Completed
• A Study of LY3462817 in Participants With Rheumatoid Arthritis — Completed
• A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE) — Stopped early
• A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3) — Stopped early
• A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus — Stopped early